CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Sunho Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Sunho Pharmaceutical Co Ltd
No. 18 Zhonghe Street
Beijing Economc & Technlgcl Dvlpmnt Zone
Phone: +86 1067881088p:+86 1067881088 BEIJING, BEJ  100176  China Ticker: 920017920017
Business Summary
Beijing Sunho Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceutical preparations. The Company's main products include compound digestive enzyme capsules, octreotide acetate, tranexamic acid injection, mecobalamin tablets, and loratadine tablets. The Company is also engaged in the provision of Chemistry, Manufacturing and Controls/ Contract Manufacturing Organization (CMC/CMO) services to pharmaceutical research institutions, startup pharmaceutical companies, and large pharmaceutical companies. The Company mainly operates its businesses in the domestic and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
2833 Medicinal chemicals and botanical products

Business Names
Business Name
430017
920017

General Information
Number of Employees: 588 (As of 12/31/2025)
Outstanding Shares: 124,832,280 (As of 3/31/2026)
Shareholders: 7,945
Stock Exchange: BJS
Fax Number: +86 1067877439


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026